Medical device recalls Moderate risk

Leica Microsystems, Inc. recalls Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diagnostic. 0.1ml NCL-CD10…

Recall date
September 3, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0341-2016
FDA classification
Class II
Brand / firm
Leica Microsystems, Inc.
Sold / distributed
Worldwide Distribution - US Nationwide, Australia, Austria, Brazil, Canada, China, Czech Republic, Finland, France, Germany, Hungary, Indonesia, Ireland, Israel, Italy, Japan, Netherlands, Norway, Romania, Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland and UK.

Why it was recalled

These Lot numbers are not stable up to the expiry date on the product labeling.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diagnostic. 0.1ml NCL-CD10-270 and 1mL NCL-CD10-270 are intended for the qualitative identification by light microscopy of CD10 molecules in paraffin sections.

Get recall alerts

Free email alert whenever Leica Microsystems, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Leica Microsystems, Inc.